FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003467979> ?p ?o ?g. }

• W2003467979 endingPage "496" @default.
• W2003467979 startingPage "492" @default.
• W2003467979 abstract "CytometryVolume 14, Issue 5 p. 492-496 Special ReportFree Access Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology† Ricardo E. Duque, Corresponding Author Ricardo E. Duque M.D. Department of Pathology, Carraway Methodist Medical Center, Norwood Clinic, Birmingham, AlabamaDepartment of Pathology, Lakeland Regional Medical Center, 1324 Lakeland Hills Blvd, Lakeland, FLSearch for more papers by this authorMichael Andreeff, Michael Andreeff Department of Hematology, Leukemia Section, University of Texas, M.D. Anderson Cancer Center, Houston, TexasSearch for more papers by this authorRaul C. Braylan, Raul C. Braylan Department of Pathology, University of Florida College of Medicine, Gainesville, FloridaSearch for more papers by this authorLawrence W. Diamond, Lawrence W. Diamond Laboratoire d'Hematologie, Hospital Henri Mondor, Creteil, FranceSearch for more papers by this authorStephen C. Peiper, Stephen C. Peiper James Graham Brown Cancer Center, Louisville, KentuckySearch for more papers by this author Ricardo E. Duque, Corresponding Author Ricardo E. Duque M.D. Department of Pathology, Carraway Methodist Medical Center, Norwood Clinic, Birmingham, AlabamaDepartment of Pathology, Lakeland Regional Medical Center, 1324 Lakeland Hills Blvd, Lakeland, FLSearch for more papers by this authorMichael Andreeff, Michael Andreeff Department of Hematology, Leukemia Section, University of Texas, M.D. Anderson Cancer Center, Houston, TexasSearch for more papers by this authorRaul C. Braylan, Raul C. Braylan Department of Pathology, University of Florida College of Medicine, Gainesville, FloridaSearch for more papers by this authorLawrence W. Diamond, Lawrence W. Diamond Laboratoire d'Hematologie, Hospital Henri Mondor, Creteil, FranceSearch for more papers by this authorStephen C. Peiper, Stephen C. Peiper James Graham Brown Cancer Center, Louisville, KentuckySearch for more papers by this author First published: 1993 https://doi.org/10.1002/cyto.990140507Citations: 70 † These consensual guidelines and recommendations address the potential utility of DNA cytometry in characterizing human malignancies. They are provided to inform laboratory personnel, pathologists, and clinicians about DNA cytometry. For individual patients, use of DNA cytometry, selection of specific techniques, and interpretation and utilization of results remains the responsibility of the attending physicians. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Literature Cited 1 Anastasi J, Bauer KD, Variakojis D: DNA aneuploidy in Hodgkin's disease. A multiparameter flow-cytometric analysis with cytologic correlation. Am J Pathol 128: 573–582, 1987. 2 Young GA, Hedley DW, Rugg CA, Iland HJ: The prognostic significance of proliferative activity in poor histology non-Hodgkin's lymphoma: A flow cytometry study using archival material. Eur J Cancer Clin Oncol 23: 1497–1504, 1987. 3 Morgan DR, Williamson JMS, Quirke P, Clayden AD, Smith MEF, O'Brien CJ, Allison DL, Child JA, Bird CC: DNA content and prognosis of non-Hodgkin's lymphoma. Br J Cancer 54: 643–649, 1986. 4 Griesser H, Wooldridge TN, Purtilo DT, Pierson J, Bast M, Wool-dridge L, Armitage JO, Weisenburger DD: Low proliferative activity is associated with favorable prognosis in peripheral T-cell lymphoma. Cancer Res 50: 4845–4848, 1990. 5 Macartney JC, Camplejohn RS, Hollowood K, Clarke D, Timothy A: DNA flow cytometry of follicular non-Hodgkin's lymphoma. J Clin Pathol 44: 215–218, 1991. 6 Macartney JC, Camplejohn RS, Alder J, Stone MG, Powell G: Prognostic importance of DNA flow cytometry in non-Hodgkin's lymphomas. J Clin Pathol 39: 542–546, 1986. 7 Rehn S, Glimelius B, Strang P, Sundstrom C, Tribukait B: Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma. Hematol Oncol 8: 1–12, 1990. 8 Lehtinen T, Aine R, Kallioniemi OP, Leino T, Hakala T, Leinikki P, Alavaikko M: Flow cytometric DNA analysis of 199 histologically favourable or unfavourable non-Hodgkin lymphomas. J Pathol 157: 27–36, 1989. 9 Cavalli C, Danova M, Gobbi P, Riccardi A, Magrini H, Mazzini G, Bertoloni D, Rutigliano L, Rossi A, Ascari E: Ploidy and proliferative activity measurement by flow cytometry in non-Hodgkin's lymphomas: Do speculative aspects prevail over clinical ones? Eur J Cancer Clin Oncol 25: 1755–1763, 1989. 10 Christensson B, Lindemalm C, Johansson B, Mellstedt H, Tribukait B, Biberfeld P: Flow cytometric analysis: A prognostic tool in non-Hodgkin's lymphoma. Leuk Res 13: 307–314, 1989. 11 Wooldridge TN, Grierson H, Weisenburger DD, Armitage JO, Sanger WG, Collins Michaeleen M, Pierson JL, Pauza ME, Fordyce R, Purtilo DT: Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma. Cancer Res 48: 6608–6613, 1988. 12 McLaughlin P, Osborne B, Johnston D, Jennings P, Butler JJ, Cabanillas F, Barlogie B: Nucleic acid flow cytometry in large cell lymphoma. Cancer Res 48: 6614–6619, 1988. 13 Griffin NR, Howard MR, O'Brien CJ, Child JA, Bird CC: Prognostic indicators in centroblastic-centrocytic lymphoma. J Clin Pathol 41: 866–870, 1988. 14 O'Brien CJ, Holgate C, Quirke P, Stuart NS, Ellis IO, Elston CW, Jones EL, Bird CC: Correlation of morphology, immunopheno-type, and flow cytometry with remission induction and survival in high grade non-Hodgkin's lymphoma. J Pathol 158: 31–39, 1989. 15 Cowan RA, Harris M, Jones M, Crowther D: DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinical correlations. Br J Cancer 60: 904–910, 1989. 16 Joensuu H, Klemi PJ, Soderstrom KO, Jalkanen S: Comparison of S-phase fraction, working formulation, and Kiel classification in non-Hodgkin's lymphoma. Cancer 68: 1564–1571, 1991. 17 Scarffe JH, Crowther D: The pre-treatment proliferative activity of non-Hodgkin's lymphoma cells. Eur J Cancer 17: 99–108, 1981. 18 Lenner P, Roos G, Johansson H, Lindh J, Dige U: Non-Hodgkin lymphoma: Multivariate analysis of prognostic factors including fraction of S-phase cells. Acta Oncol 26: 179–183, 1987. 19 Bauer KD, Merkel DE, Winter JN, Marder RJ, Hauck WW, Wallemark CB, Williams TJ, Variakojis D: Prognostic implications of ploidy and proliferative activity in diffuse large cell lymphomas. Cancer Res 46: 3173–3178, 1986. 20 Andreeff M, Hansen H, Cirrincione C, Filippa D, Thaler H: Prognostic value of DNA/RNA flow cytometry of B-cell non-Hodgkin's lymphoma: Development of laboratory model and correlation with four taxonomic systems. Ann NY Acad Sci 468: 368–386, 1986. 21 Braylan RC, Diamond LW, Powell ML, Harty Golder B: Percentage of cells in the S phase of the cell cycle in human lymphoma determined by flow cytometry. Cytometry 1: 171–174, 1980. 22 Diamond LW, Nathwani BN, Rappaport H: Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia. Cancer 50: 1122–1135, 1982. 23 Srigley J, Barlogie B, Butler JJ, Osborne B, Blick M, Johnston D, Kantarjian H, Reuben J, Batsakis J, Freireich EJ: Heterogeneity of non-Hodgkin's lymphoma probed by nucleic acid cytometry. Blood 65: 1090–1096, 1985. 24 Christensson B, Tribukait B, Linder IL, Ullman B, Biberfeld P: Cell proliferation and DNA content in non-Hodgkin's lymphoma: Flow cytometry in relation to lymphoma classification. Cancer 58: 1295–1304, 1986. 25 Barlogie B, Alexanian R, Dixon D, Smith L, Smallwood L, Delasalle K: Prognostic implications of tumor cell DNA and RNA content in multiple myeloma. Blood 66: 338–341, 1985. 26 Morgan RJ Jr., Gonchoroff NJ, Katzmann JA, Witzig TE, Kyle RA, Greipp PR: Detection of hypodiploidy using multi-parameter flow cytometric analysis: A prognostic indicator in multiple myeloma. Am J Hematol 30: 195–200, 1989. 27 Tafuri A, Meyers J, Lee BJ, Andreeff M: DNA and RNA flow cytometric study in multiple myeloma. Clinical correlations. Cancer 67: 449–454, 1991. 28 Barlogie B, Schumann J, Johnson TS, Drewinko B, Swartzendruber DE, Gohde W, Andreeff M: Flow cytometry in clinical cancer research. Cancer Res 43: 3982–3986, 1983. 29 Hiddemann W, Wormann B, Ritter J, et al: Frequency and clinical significance of DNA aneuploidy in acute leukemia. In: Clinical Cytometry, M Andreeff (ed). Ann NY Acad Sci, New York, 1986, pp 227–240. 30 Brodeur GM, Williams DL, Look AT, Bowman WP, Kalwinsky DK: Near-haploid acute lymphoblastic leukemia: A unique subgroup with a poor prognosis. Blood 58: 14, 1981. 31 Andreeff M, Melamed MR, Miller D, Clarkson BD: Near haploid acute lymphoblastic leukemia (ALL): A poor prognosis subgroup identified and monitored by flow cytometry. Cytometry 2: 87, 1981. 32 Look AT, Roberson PK, Williams DL, Rivera G, Bowman WP, Pui CH, Ochs J, Abromowitch M, Kalwinsky D, Dahl GV, et al: Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood 65: 1079–1086, 1985. 33 Woermann B, Hiddemann W, Ritter J, et al: Incidence and prognostic significance of DNA aneuploidy in childhood lymphoblastic leukemia. In: Tumor Aneuploidy, T Buechner (ed). Springer-Verlag, Berlin, 1985, pp 53–62. 34 Hiddemann W, Wormann B, Messerer D, Springefeld R, Buechner T: Analysis of the cellular DNA and RNA content in acute leukemias by flow cytometry. J Cancer Res Clin Oncol 116: 507–512, 1990. 35 Andreeff M, Edner A, Thongprasert S, et al: Multiparameter flow cytometry for determination of ploidy, proliferation and differentiation in acute leukemia: Treatment effects and prognostic value. In: Tumor Aneuploidy, T Buechner (ed.) Springer-Verlag, Berlin, 1985, p 81. 36 Edner A, Melamed MR, Andreeff M: Detection of central nervous system relapse in acute leukemia by multiparameter flow cytometry of DNA, RNA, and CALLA. In: Clinical Cytometry, M Andreeff (ed). Ann NY Acad Sci New York, 1986, pp 241–255. 37 Andrew CHP, Carroll A, Head D, Raimondi SC, Schuster JJ, Crist WM, Link MP, Borowitz MJ, Behm FG, Land VJ, Nash MB, Pullen JD, Look AT: Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood. Blood 76: 590–596, 1992. 38 Edner A, Grabowski E, Al Katib A, Andreeff M: Common acute lymphoblastic leukemia characterized by four different DNA stemlines with heterogeneity in RNA content, antigen expression and sensitivity to chemotherapy. Leuk Res 10: 671–676, 1986. 39 Paietta E, Andreeff M, Papenhausen P, Gucalp R, Wiernik PH: Distinct antigen expression related to DNA ploidy in a case of biphenotypic leukemia. Leukemia 3: 76, 1989. 40 Andreeff, M. Biological Characterization and Therapy Monitoring of Leukemia By Flow Cytometry. In: Flow Cytometry in Hematology, OD Laerum, R Bjerknes (ed). Academic Press, London, 1992, pp 231–263. 41 Terstappen LW, Safford M, Unterhalt M, Koneman S, Zurletter K, Piechotka K, Drescher M, Aul C, Buechner T, Hiddemann W, Wormann B: Flow cytometric characterization of acute myeloid leukemia: IV. Comparison to the differentiation pathway of normal hematopoietic progenitor cells. Leukemia 6: 993, 1992. 42 Hiddemann W, Buechner T, Andreeff M, Woermann B, Melamed MR, Clarkson BD: Bone marrow biopsy instead of marrow juice for cell kinetic analysis: Comparison of bone marrow biopsy and aspiration material. Leuk Res 6: 601, 1982. 43 Tafuri A, Andreeff M: Cell kinetic modulation of hematologic malignanciesmby cytokines, F Herrman (eds). Marcel Dekker, New York, 1990, p 381. 44 Bettelheim P, Muhm M, Valent P, Geissler K, Hinterberger W, Haas O, Speiser W, Sunder-Plassman G, Vieder L, Andreeff M, Lechner K: RHuGM-CSF in combination with standard induction chemotherapy ( “3 + 7”) in patients with de-novo acute myeloid leukemia. Molec Biother 1: 61, 1989 (Abstract). 45 Andreeff M, Assing G, Cirrincione C: Prognostic value of DNA/RNA flow cytometry in myeloblastic and lymphoblastic leukemia in adults: RNA content and S-phase predict remission duration and survival in multi-variate analysis. In: Clinical Cytometry, M Andreeff (ed). NY Acad Sci, New York, 1986, pp 387–406. 46 Maddox AM, Johnston DA, Barlogie B, Youness E, Keating M, Freidreich EJ: DNA-RNA measurements in patients with acute leukemia undergoing remission induction therapy. J Clin Oncol 3: 799–808, 1985. 47 Walters RS, Johnston DA, Dixon DO, et al: Nucleic acid flow cytometry: An aid to diagnosis and prognosis in acute leukemia in adults. In: The Acute Leukemias, SA Stass (ed). Marcel Dekker, New York, 1987, pp 203–245. 48 Andreeff M, Darzynkiewicz Z, Sharpless TK, Clarkson BD, Melamed MR: Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. Blood 55: 282, 1980. 49 Lichtman SM, Andreeff M: Flow cytometric analysis of cytokinetics of L3-acute lymphoblastic leukemia/lymphoma. Leuk Res 16: 853, 1992. 50 Clark R, Peters S, Hoy T, Smith S, Whittaker K, Jacobs A: Prognostic importance of hypodiploid hemopoietic precursors in myelodysplastic syndromes. N Engl J Med 314: 1472–1475, 1986. 51 Peters SW, Clark RE, Hoy T, Jacobs A: DNA content and cell cycle analysis of bone marrow cells in myelodysplastic syndromes (MDS). Br J Haematol 62: 239–245, 1986. 52 Braylan RC, Benson NA, Nourse VA: Cellular DNA of human neoplastic B-cells measured by flow cytometry. Cancer Res 44: 5010–5016, 1984. 53 Rabinovitch PS: Practical considerations for DNA content and cell cycle analysis. In, Duque RE, TV Shankey (eds). Williams and Wilkins, Baltimore, 1993, pp 117–142. 54 Benson NA, Braylan RC: Sensitivity in detaction of aneuploidy by flow cytometric DNA quantitation: A model describing contributing parameters. Cytometry (A). Supplement 2, 1988. Citing Literature Volume14, Issue51993Pages 492-496 ReferencesRelatedInformation" @default.
• W2003467979 created "2016-06-24" @default.
• W2003467979 creator A5004888325 @default.
• W2003467979 creator A5038419986 @default.
• W2003467979 creator A5067074464 @default.
• W2003467979 creator A5077628886 @default.
• W2003467979 creator A5083134524 @default.
• W2003467979 date "1993-01-01" @default.
• W2003467979 modified "2023-10-11" @default.
• W2003467979 title "Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology" @default.
• W2003467979 cites W116715822 @default.
• W2003467979 cites W1505185876 @default.
• W2003467979 cites W195883502 @default.
• W2003467979 cites W1972537474 @default.
• W2003467979 cites W1980495298 @default.
• W2003467979 cites W1982632629 @default.
• W2003467979 cites W1984761285 @default.
• W2003467979 cites W1985086148 @default.
• W2003467979 cites W1988209797 @default.
• W2003467979 cites W1988791378 @default.
• W2003467979 cites W1989052068 @default.
• W2003467979 cites W1991904887 @default.
• W2003467979 cites W1999904677 @default.
• W2003467979 cites W2004934355 @default.
• W2003467979 cites W2005770449 @default.
• W2003467979 cites W2015967879 @default.
• W2003467979 cites W2017527904 @default.
• W2003467979 cites W2021893910 @default.
• W2003467979 cites W2024527537 @default.
• W2003467979 cites W2027649705 @default.
• W2003467979 cites W2054732898 @default.
• W2003467979 cites W2072679601 @default.
• W2003467979 cites W2087869106 @default.
• W2003467979 cites W2091863341 @default.
• W2003467979 cites W2095280237 @default.
• W2003467979 cites W2138319630 @default.
• W2003467979 cites W2226535672 @default.
• W2003467979 cites W2231572595 @default.
• W2003467979 cites W2396068685 @default.
• W2003467979 cites W4231029422 @default.
• W2003467979 cites W4253494646 @default.
• W2003467979 cites W46933350 @default.
• W2003467979 cites W1995023099 @default.
• W2003467979 doi "https://doi.org/10.1002/cyto.990140507" @default.
• W2003467979 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8354121" @default.
• W2003467979 hasPublicationYear "1993" @default.
• W2003467979 type Work @default.
• W2003467979 sameAs 2003467979 @default.
• W2003467979 citedByCount "91" @default.
• W2003467979 countsByYear W20034679792012 @default.
• W2003467979 countsByYear W20034679792013 @default.
• W2003467979 countsByYear W20034679792014 @default.
• W2003467979 countsByYear W20034679792016 @default.
• W2003467979 countsByYear W20034679792017 @default.
• W2003467979 countsByYear W20034679792020 @default.
• W2003467979 countsByYear W20034679792022 @default.
• W2003467979 countsByYear W20034679792023 @default.
• W2003467979 crossrefType "journal-article" @default.
• W2003467979 hasAuthorship W2003467979A5004888325 @default.
• W2003467979 hasAuthorship W2003467979A5038419986 @default.
• W2003467979 hasAuthorship W2003467979A5067074464 @default.
• W2003467979 hasAuthorship W2003467979A5077628886 @default.
• W2003467979 hasAuthorship W2003467979A5083134524 @default.
• W2003467979 hasBestOaLocation W20034679791 @default.
• W2003467979 hasConcept C104317684 @default.
• W2003467979 hasConcept C174475383 @default.
• W2003467979 hasConcept C203014093 @default.
• W2003467979 hasConcept C2779060813 @default.
• W2003467979 hasConcept C30481170 @default.
• W2003467979 hasConcept C54355233 @default.
• W2003467979 hasConcept C553184892 @default.
• W2003467979 hasConcept C70721500 @default.
• W2003467979 hasConcept C86803240 @default.
• W2003467979 hasConceptScore W2003467979C104317684 @default.
• W2003467979 hasConceptScore W2003467979C174475383 @default.
• W2003467979 hasConceptScore W2003467979C203014093 @default.
• W2003467979 hasConceptScore W2003467979C2779060813 @default.
• W2003467979 hasConceptScore W2003467979C30481170 @default.
• W2003467979 hasConceptScore W2003467979C54355233 @default.
• W2003467979 hasConceptScore W2003467979C553184892 @default.
• W2003467979 hasConceptScore W2003467979C70721500 @default.
• W2003467979 hasConceptScore W2003467979C86803240 @default.
• W2003467979 hasIssue "5" @default.
• W2003467979 hasLocation W20034679791 @default.
• W2003467979 hasLocation W20034679792 @default.
• W2003467979 hasOpenAccess W2003467979 @default.
• W2003467979 hasPrimaryLocation W20034679791 @default.
• W2003467979 hasRelatedWork W1641042124 @default.
• W2003467979 hasRelatedWork W1990804418 @default.
• W2003467979 hasRelatedWork W1993764875 @default.
• W2003467979 hasRelatedWork W2013243191 @default.
• W2003467979 hasRelatedWork W2082860237 @default.
• W2003467979 hasRelatedWork W2126197617 @default.
• W2003467979 hasRelatedWork W2130076355 @default.
• W2003467979 hasRelatedWork W2151865869 @default.
• W2003467979 hasRelatedWork W1550204661 @default.
• W2003467979 hasRelatedWork W1981780139 @default.
• W2003467979 hasVolume "14" @default.

• next